Moreover, in vitro experiments using Tau aggregates isolated from human AD brains confirmed that the activity of proteasome could be reduced by aggregated Tau, whereas non-aggregated Tau had no such effect [89], which further verified the interaction between aggregated Tau and proteasome. Here, MAPT is linked to Alzheimer disease.